Product Information
VIMPAT 10 MG/ML SOLUTION is a brand product labeled by UCB, Inc., priced at $2.2976 per ML under NDC 00131541072. Its NADAC has been published 319 times since Aug 26, 2020.
FDA first approved this application on Apr 20, 2010. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
UCB, Inc.NDC
00131541072
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022255FDA Approved
4/20/2010
TE Code
AA
On Market Since
4/20/2010
Pharmacological Classes
Price Statistics
The NADAC for VIMPAT 10 MG/ML SOLUTION has been published 319 times since Aug 26, 2020, and over the history we have for it it has risen 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2976 per ML |
|---|---|
| All-time high | $2.2997 (May 13, 2026) |
| All-time low | $1.7620 (Aug 26, 2020) |
| 52-week high | $2.2997 |
| 52-week low | $2.2414 |
| Median price | $2.1003 |
| Average price | $2.0814 |
| Largest weekly change | +6.9% (Jan 12, 2022) |
| Weeks tracked | 319 |
| Tracking since | Aug 26, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lacosamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
UCB, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VIMPAT 10 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for VIMPAT 10 MG/ML SOLUTION, manufactured by UCB, Inc., is $2.2976 per ML (NDC 00131541072), effective Sep 30, 2026.
How has the price of VIMPAT 10 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for VIMPAT 10 MG/ML SOLUTION has risen 30.4%. It has been tracked across 319 weekly CMS publications since Aug 26, 2020.
What are the highest and lowest recorded NADAC prices for VIMPAT 10 MG/ML SOLUTION?
Since Aug 26, 2020, the NADAC for VIMPAT 10 MG/ML SOLUTION has ranged from a low of $1.7620 (Aug 26, 2020) to a high of $2.2997 (May 13, 2026), with a median of $2.1003 per ML.
Are there cheaper alternatives to VIMPAT 10 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of VIMPAT 10 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VIMPAT 10 MG/ML SOLUTION?
VIMPAT 10 MG/ML SOLUTION (NDC 00131541072) is labeled by UCB, Inc., and CMS classifies it as a brand product.